HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hydron Technologies

This article was originally published in The Rose Sheet

Executive Summary

Signs a letter of intent June 13 to grant Norway-based Nycomed Pharma AS the exclusive marketing and distribution rights to its Hydron skin care products in Norway, Sweden, Denmark and Finland. Under a completed agreement, Nycomed Pharma would distribute the products to outlets including perfumeries, pharmacies and specialty stores. The agreement, the terms of which are still under negotiation, is expected to be finalized by Dec. 31. Separately, Hydron appoints Thomas Burns chief financial officer. Prior to joining Hydron Technologies, Burns was an audit senior manager for Ernst & Young of West Palm Beach
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS000562

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel